Related Experiment Video
Updated: Sep 18, 2025
08:48
Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
7.1K
Host targets of candidalysin
Jianfeng Lin1, Scott G Filler1,2
1Division of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Plos Pathogens
|June 23, 2025
Summary
Candida albicans, a common fungus, releases candidalysin, a toxin that harms host cells and triggers immune responses. This toxin is crucial for both causing disease and maintaining a harmless relationship with the host.
Area of Science:
- Mycology
- Immunology
- Microbiology
Background:
- Candida albicans is a fungus residing in the human microbiota, capable of causing superficial to life-threatening infections.
- Hyphae of C. albicans secrete candidalysin, a cytolytic peptide toxin.
- Candidalysin is implicated in both the pathogenic and commensal roles of C. albicans.
Purpose of the Study:
- To review the host targets of candidalysin.
- To elucidate how candidalysin-mediated host cell modulation influences C. albicans-host interactions.
Main Methods:
- Literature review of studies on candidalysin and its host interactions.
- Analysis of experimental data on candidalysin's effects on host cells and immune pathways.
Main Results:
- Candidalysin directly damages host cells, contributing to tissue invasion and inflammation.
- Host cell responses to candidalysin involve activation of innate and adaptive immunity.
- Specific host targets and signaling pathways modulated by candidalysin have been identified.
Conclusions:
- Candidalysin is a key virulence factor in C. albicans infections.
- Understanding candidalysin's host interactions is vital for developing new therapeutic strategies.
- Candidalysin's dual role highlights the complexity of host-microbe dynamics.
Related Concept Videos
01:26Targets for Drug Action: Overview
7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
01:22Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K